Health In Tech, Inc. Class A Common Stock (HIT)vsZepp Health Corp (ZEPP)
HIT
Health In Tech, Inc. Class A Common Stock
$1.45
0.00%
TECHNOLOGY · Cap: $98.29M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 677% more annual revenue ($258.90M vs $33.33M). HIT leads profitability with a 3.8% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
HIT
Avoid35
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+62.4%
Fair Value
$2.87
Current Price
$1.45
$1.42 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 53.1% year-over-year
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
3.8% margin — thin
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : HIT
The strongest argument for HIT centers on Revenue Growth. Revenue growth of 53.1% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : HIT
The primary concerns for HIT are Market Cap, Profit Margin, P/E Ratio. A P/E of 75.0x leaves little room for execution misses. Thin 3.8% margins leave little buffer for downturns.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
HIT is growing revenue faster at 53.1% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 35/100) and 43.0% revenue growth. HIT offers better value entry with a 62.4% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Health In Tech, Inc. Class A Common Stock
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Health In Tech, Inc. (HIT) is at the forefront of the digital health revolution, dedicated to enhancing healthcare delivery through innovative technology solutions. By harnessing advanced data analytics and proprietary software, HIT empowers healthcare providers and patients to make informed decisions, resulting in improved patient outcomes and operational efficiencies. The company's robust focus on compliance and cybersecurity uniquely positions it to thrive in the rapidly expanding digital health market. As the industry continues to evolve, HIT is poised to establish itself as a key player in advancing technology-driven healthcare solutions globally.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?